TrialEBioMedicine2017

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

Takehiko Fujino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.